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Abstract 
L-Threonine, technically pure, is a feed additive produced by fermentation using a genetically modified 
strain of Escherichia coli. The Panel on Additives and Products or Substances used in Animal Feed 
(FEEDAP) of the European Food Safety Authority (EFSA) issued an opinion on the safety and efficacy 
of the product, in which it could not conclude on the safety of this additive for target animals, 
consumer, user and the environment, due to insufficient characterisation of the genetic modification. 
The European Commission asked EFSA to deliver an opinion on the safety of L-threonine, technically 
pure, as a nutritional additive for all animal species based on additional data submitted by the 
applicant. Neither the production strain nor its recombinant genes are present in the final product. 
Therefore, the FEEDAP Panel concludes that L-threonine produced using E. coli CGMCC 3703 does not 
raise any safety concern for the target species, consumer, user and the environment with regard to 
the genetic modification of the production strain. The FEEDAP Panel reiterated their concerns on the 
safety of amino acids, including L-threonine, for target species when administered simultaneously via 
water for drinking due to amino acid imbalances. As the estimated maximum exposure to endotoxins 
by inhalation was below the provisional occupational exposure limit, no risk from the exposure to 
endotoxins for people handling the additive is expected. 
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Summary 
Following a request from the European Commission (EC), the European Food Safety Authority (EFSA) 
was asked to deliver a scientific opinion on the safety of L-threonine, technically pure, produced by 
fermentation using the genetically modified strain Escherichia coli CGMCC 3703 for all animal species. 
In 2014, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) of EFSA 
adopted an opinion on the safety and efficacy of L-threonine produced by fermentation with E. coli 
CGMCC 3703. The FEEDAP Panel could not conclude on the safety of that product for target animals, 
consumer, user and the environment because the genetic modification, including the 
presence/absence of recombinant DNA and of antibiotic resistance genes in the product, was 
insufficiently characterised.  
The applicant provided additional information in relation to the characterisation of the production 
microorganism, the characterisation of the additive and its stability. The FEEDAP Panel has performed 
the assessment of those new data following an approach in line with the principles laid down in 
Regulation (EC) No 429/2008 and the relevant guidance documents. 
Neither the production strain nor its recombinant genes were present in the final product. Therefore, 
the FEEDAP Panel concluded that L-threonine, manufactured by fermentation with E. coli CGMCC 
3703, did not raise safety concerns for the target species, consumers, users and the environment with 
regard to the genetic modification of the production strain. 
The FEEDAP Panel reiterated their concerns on the safety of amino acids, including L-threonine, for 
target species when administered simultaneously via water for drinking due to amino acid imbalances. 
As the estimated maximum exposure to endotoxins by inhalation was below the provisional 
occupational exposure limit, no risk from the exposure to endotoxins for people handling the additive 
is expected.  
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1. Introduction  
1.1. Background and Terms of Reference as provided by the requestor 
Regulation (EC) No 1831/2003 establishes rules governing the Community authorisation of additives 
for animal nutrition and, in particular, Article 9 defines the terms of the authorisation by the 
Commission. 
The applicant, GBT Europe GmbH, is seeking a Community authorisation of L-threonine, technically 
pure, produced by fermentation using Escherichia coli to be used as a nutritional additive for all 
animal species. (Table 1) 
Table 1:  Description of the substances 
Category of additive Nutritional additive 
Functional group of additive Amino acids, their salts and analogues 
Description L-Threonine, technically pure, produced by Escherichia coli 
Target animal category All animal species 
Applicant GBT Europe GmbH 
Type of request New opinion 
 
On 10 April 2014, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) 
of the European Food Safety Authority (‘Authority’), in its opinion on the safety and efficacy of the 
product could not conclude on the safety of the L-threonine produced by fermentation with this 
recombinant strain of E. coli for target animals, consumer, user and the environment. Regardless of 
the assessment of the genetic modification, the FEEDAP Panel had concerns about the safety of amino 
acids, including L-threonine, for target species when administered simultaneously via water for 
drinking due to amino acids imbalances. 
The Commission gave the opportunity to the applicant to submit complementary information in order 
to complete the assessment on the safety and to allow a revision of the Authority's opinion. 
The Commission has now received new data on the safety of L-threonine, technically pure, produced 
by fermentation using E. coli CGMCC 3703. 
In view of the above, the Commission asks the Authority to deliver a new opinion on the safety of 
L-threonine, technically pure, produced by fermentation using E. coli CGMCC 3703 as a nutritional 
additive for all animal species based on the additional data submitted by the applicant. 
1.2. Additional information  
In 2012, the European Food Safety Authority (EFSA) was requested by the European Commission (EC) 
to re-evaluate the product L-threonine produced by E. coli CGMCC 3703 when used as a nutritional 
additive (functional group: functional group amino acids, their salts and analogues) for all animal 
species without time limit and without maximum content in feed (EFSA FEEDAP Panel, 2014). The 
amino acid L-threonine itself was considered safe for target animals, consumers and the environment. 
However, the genetic modification, including the possible presence of recombinant DNA and of 
antibiotic resistance genes in the product, was insufficiently characterised. Consequently, the FEEDAP 
Panel could not conclude on the safety of the L-threonine produced by fermentation using E. coli 
CGMCC 3703 for target animals, consumer, user and the environment. 
The applicant has provided additional information on the characterisation of the production 
microorganism, the characterisation of the additive and its stability. 
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2. Data and Methodologies  
2.1. Data 
The present assessment is based on the data submitted by the applicant in the form of additional 
information1 following a previous application on the same product.2 
2.2. Methodologies 
The approach followed by the FEEDAP Panel to assess the characterisation and safety of L-threonine 
produced by E. coli CGMCC 3703 is consistent with the principles laid down in Regulation (EC) No 
429/20083 and the relevant guidance documents: Guidance on nutritional additives (EFSA FEEDAP 
Panel, 2012a), Guidance on the risk assessment of genetically modified microorganisms and their 
products intended for food and feed use (EFSA GMO Panel, 2011), Technical guidance - Update of the 
criteria used in the assessment of bacterial resistance to antibiotics of human or veterinary importance 
(EFSA, 2008, revised in 2012b), Technical Guidance: Microbial Studies (EFSA, 2008) and Guidance on 
studies concerning the safety of use of the additive for users/workers (EFSA FEEDAP Panel, 2012c).  
3. Assessment 
L-Threonine, technically pure, (minimum content of L-threonine 98%, ‘as is’ basis) was first authorised 
for use in animal nutrition by Directive 88/485/EEC. It is currently included in the European Union 
Register of Feed Additives pursuant to Regulation (EC) No 1831/2003 concerning additives in 
feedingstuffs. 
The current application is for the authorisation of L-threonine, technically pure, produced by a 
genetically modified (GM) strain of E. coli (CGMCC 3703), a derivative of E. coli K-12. It is intended to 
be used in all animal species as a nutritional additive in feed and in water for drinking.  
3.1. Characterisation  
This product has been characterised in a previous scientific opinion (EFSA FEEDAP Panel, 2014). 
Additional data have been submitted on the characterisation of the production strain, on the physical 
properties of the additive and its stability in complete feed, and on the manufacturing process.  
3.1.1. Characterisation of the production organism4 
The technical dossier contains information on the susceptibility of the production strain against the list 
of antibiotics proposed for E. coli in the technical guidance on the assessment of bacterial 
susceptibility to antimicrobials of human and veterinary importance (EFSA FEEDAP Panel, 2012).5  
Although the parent strain E. coli K-12 is not included in EFSA’s qualified presumption of safety (QPS) 
list (EFSA BIOHAZ Panel, 2013), it is not considered a human or animal pathogen, it has a long history 
of apparent safe use in industrial production and is scientifically recognised as a safe bacterial strain 
not producing toxic substances (EPA, 1997; Gorbach, 1978). E. coli K-12 has been used widely as a 
model organism in research in microbial genetics and physiology, and has widespread use in industrial 
applications. E. coli K-12 is one of the most extensively studied of all microorganisms. Its genome 
sequence was published in 1997 (Blattner et al., 1997) and confirmed the absence of toxigenic 
potential. It does not appear in the most comprehensive review of pathogenic E. coli published by 
Nataro and Kaper (1998). Indeed, strain K-12 is commonly used as a ‘base model’ (safety reference 
                                                          
1
  Dossier reference: FAD-2015-0012. 
2
  Dossier reference: FAD-2010-0289. 
3
  Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC) No 
1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications and 
the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1. 
4  This section of the scientific output is temporarily unavailable to the public pending a final decision on the confidentiality 
request submitted by the applicant. A revised version of the opinion will be made available as soon as this decision-making 
process is concluded. 
5
  Technical dossier/Supplementary information April 2015/Annex 2.1.3. 
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strain) against which the safety of other E. coli strains is assessed, (see Kaper et al., 2004). It can be 
therefore assumed that there is no antibiotic or enterotoxin production from E. coli K-12. 
Characterisation of the genetic modification6 
In the former assessment of the production strain (EFSA FEEDAP Panel, 2014), the genetic 
modification, including the presence/absence of recombinant DNA and of antibiotic resistance genes in 
the product, was insufficiently characterised. 
The applicant provided additional information7 which contains sufficient details on the recipient 
microorganism including safety aspects, the origin and function of the different genetic elements 
introduced in the production strain, the genetic modification process and the genetic and phenotypic 
traits introduced. 
3.1.2. Physical properties 
The applicant submitted data on dusting potential measured in three batches of the final product 
(Stauber–Heubach). The values ranged between 0.10 and 0.13 g/m3.8 
3.1.3. Manufacturing process9 
The applicant declared that no antimicrobial compounds (including antibiotics) were used in the 
production process.10 It has been demonstrated that the final product does not contain antimicrobial 
compounds.11 
Neither viable cells of the production strain,12 nor its recombinant DNA was detected in three batches 
of the final product.13 
3.1.4. Stability and homogeneity 
In the previous opinion, the stability of the additive in complete feed and the capacity of the additive 
to distribute homogeneously in feed were evaluated by measuring total threonine (protein-bound plus 
free L-threonine) instead of free L-threonine. The FEEDAP Panel noted that the results obtained might 
not fully represent the stability of the added free amino acid or its ability to distribute homogeneously 
in compound feedingstuffs. 
A new stability study in complete feed for piglets was provided. L-Threonine (three different batches) 
was used to supplement (0.15%) a mash and pelleted complete feed for piglets (three batches; total 
L-threonine content: 0.85%). Samples were collected after mixing and after pelleting at 80ºC. The 
feedingstuffs were stored in paper bags for 3 months at 5–30ºC and 30–75% relative humidity. No 
losses were detected as a result of processing or storage for three months.14 
Free threonine was analysed in 10 subsamples of the above pelleted complete feed for piglets to 
determine the capacity of the additive to distribute homogeneously in feed. The coefficient of variation 
was 4.4%.15 
                                                          
6  This section of the scientific output is temporarily unavailable to the public pending a final decision on the confidentiality 
request submitted by the applicant. A revised version of the opinion will be made available as soon as this decision-making 
process is concluded. 
7
  Technical dossier/Section II/Annex 2.1.1. 
8
  Technical dossier/Supplementary information April 2015/Annex 2.1.9. 
9  This section of the scientific output is temporarily unavailable to the public pending a final decision on the confidentiality 
request submitted by the applicant. A revised version of the opinion will be made available as soon as this decision-making 
process is concluded. 
10
 Technical dossier/Supplementary information April 2015/Annexes 2.2.1 and 2.2.2. 
11
 Technical dossier/Supplementary information April 2015/Annexes 2.1.5 to 2.1.7 and Annex 2.1.4. 
12
 Technical dossier/Supplementary information April 2015/Annex 2.2.4 and Supplementary information September 2015/Annex II. 
13
 Technical dossier/ Section II/Annex 2.2.5–2.2.10 and Supplementary information September 2015/Annex I. 
14
 Technical dossier/Supplementary information April 2015/Annex 2.1.8. 
15
 Technical dossier/Supplementary information April 2015/Annex 2.1.8. 
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3.2. Safety16 
In the previous scientific opinion (EFSA FEEDAP Panel, 2014), the genetic modification of the 
production strain was insufficiently characterised and the safety of the strain could not be assessed. 
The applicant provided sufficient information that neither the production strain nor its recombinant 
genes are present in the final product, given the limits of detection provided. Therefore, L-threonine, 
manufactured by fermentation with E. coli CGMCC 3703, does not raise any safety concern for the 
target species, the consumer, the user and the environment with regard to the genetic modification of 
the production strain. 
The applicant did not provide new data on the safety of the product for target species when 
administered in the diet and in addition via water for drinking. The FEEDAP Panel reiterates its 
concerns on the safety of the amino acid L-threonine for target species when administered via water 
for drinking. 
The applicant has submitted new data on the dusting potential of the additive that allows estimating 
the risk posed by the bacterial endotoxin present in the final product for the user when exposed by 
inhalation. The production species, E. coli, is a Gram-negative bacterium. Although the K-12 strain and 
its derivatives are safe from the point of view of enterotoxins and other virulence factors (Gorbach, 
1978; EPA, 1997; Bauer et al., 2007), E. coli K-12 retains lipopolysaccharide in its cell envelope (Luchi 
and Morrison, 2000; Svensson et al.; 2005, Gao et al., 2006) which potentially may result in endotoxin 
activity in the final product. The user can suffer from occupational respiratory disease depending on 
the level of endotoxins in the air and dust (Rylander, 1999; Thorn, 2001). The bacterial endotoxin 
activity was up to 0.55 IU/mg.17 Dusting potential was measured in three batches and ranged 
between 0.10 and 0.13 g/m3. Summary data provided for three batches indicate that 7% (w/w) of 
particles have a diameter below 100 m and 1.7% < 50 m.18 
The scenario used to estimate the exposure of persons handling the additive to endotoxins in the 
dust, based on the EFSA Guidance on user safety (2012c) is described in Appendix A. The health 
based recommended threshold for the quantity of inhaled endotoxins per working day is 900 IU, 
derived from provisional occupational exposure limits given by the Dutch Expert Committee on 
Occupational Safety (DECOS) (Health Council of the Netherlands, 2010) and the UK Health and Safety 
Executive (HSE, 2013). Based upon the calculation of the potential endotoxin content in dust, the 
inhalation exposure could be up to 40 endotoxin IU per eight-hour working day, indicating no risk 
from the exposure to endotoxins for people handling the additive. 
4. Conclusions 
Neither the production strain nor its recombinant genes are present in the final product. Therefore, 
the FEEDAP Panel concludes that L-threonine, manufactured by fermentation using E. coli CGMCC 
3703, does not raise safety concerns for the target species, consumers, users and the environment 
with regard to the genetic modification of the production strain. 
The FEEDAP Panel reiterates their concerns on the safety of amino acids, including L-threonine, for 
target species when administered simultaneously via water for drinking. 
As the estimated maximum exposure to endotoxins by inhalation is below the provisional occupational 
exposure limit, no risk from the exposure to endotoxins for people handling the additive is expected. 
5. Recommendations  
The description of the additive should contain the statement ‘produced by fermentation with 
Escherichia coli CGMCC 3703’. 
                                                          
16  This section of the scientific output is temporarily unavailable to the public pending a final decision on the confidentiality 
request submitted by the applicant. A revised version of the opinion will be made available as soon as this decision-making 
process is concluded. 
17
 Technical dossier FAD-2010-0289/Supplementary information November 2013/Annex 1. 
18
 Technical dossier FAD-2010-0289/Supplementary information January 2013/Attachment 2. 
L-Threonine produced by E. coli for all animal species 
 
 
 
www.efsa.europa.eu/efsajournal 9 EFSA Journal 2016;14(1):4344 
 
Documentation provided to EFSA  
1. L-Threonine technically pure produced by fermentation with E. coli. Supplementary information. 
April 2015. Submitted by Global Bio-Chem (GBT Europe GmbH). 
2. L-Threonine technically pure produced by fermentation with E. coli. Supplementary information. 
September 2015. Submitted by Global Bio-Chem (GBT Europe GmbH). 
References 
Bauer AP, Dieckmann SM, Ludwig W and Schleifer KH, 2007. Rapid identification of Escherichia coli 
safety and laboratory strain lineages based on Multiplex-PCR. Federation of European 
Microbiological Societies Microbiology Letters, 269, 36–40. 
Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode 
CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B and Shao Y, 
1997. The complete genome sequence of Escherichia coli K-12. Science, 277, 1453–1462. 
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), 2008. Guidance 
on microbial studies. The EFSA Journal (2008) 836, 1-3. 
EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), 
2012a. Guidance for the preparation of dossiers for nutritional additives. EFSA Journal 
2012;10(1):2535, 14 pp. doi:10.2903/j.efsa.2012.2535 
EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), 
2012b. Guidance on the assessment of bacterial susceptibility to antimicrobials of human and 
veterinary importance. EFSA Journal 2012;10(6):2740, 10 pp. doi:10.2903/j.efsa.2012.2740 
EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), 
2012c. Guidance on studies concerning the safety of use of the additive for users/workers. EFSA 
Journal 2012;10(1):2539, 5 pp. doi:10.2903/j.efsa.2012.2539 
EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), 2014. 
Scientific Opinion on the safety and efficacy of L-threonine produced by Escherichia coli for all 
animal species, based on a dossier submitted by HELM AG on behalf of Global Bio-Chem 
Technology. EFSA Journal 2014;12(5):3674, 3 pp. doi:10.2903/j.efsa.2014.3674 
EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), 2015. 
Scientific Opinion on the safety and efficacy of L-threonine produced by Escherichia coli for all 
animal species based on a dossier submitted by HELM AG on behalf of Meihua Holdings Group Co. 
Ltd. EFSA Journal 2015;13(3):4051, 17 pp. doi:10.2903/j.efsa.2015.4051 
EFSA GMO Panel (EFSA Panel on Genetically Modified Organisms), 2011. Scientific Opinion on 
Guidance on the risk assessment of genetically modified microorganisms and their products 
intended for food and feed use. EFSA Journal 2011;9(6):2193, 54 pp. 
doi:10.2903/j.efsa.2011.2193 
EPA (US Environmental Protection Agency), 1997. Escherichia coli K-12 derivatives final risk 
assessment. Available online: http://epa.gov/biotech_rule/pubs/fra/fra004.htm 
Gao B, Wang Y and Tsan MF, 2006. The heat sensitivity of cytokine-inducing effect of 
lipopolysaccharide. Journal of Leukocyte Biology, 80, 359–366. 
Gorbach SL, 1978. Risk assessment of recombinant DNA experimentation with Escherichia coli K12. 
Proceedings from a workshop at Falmouth, Massachusetts. Journal of Infectious Diseases, 137, 
613–714. 
Health Council of the Netherlands, 2010. Endotoxins. Health-based recommended occupational 
exposure limit. Publication no 2010/04OSH, 100 pp. 
HSE (Health and Safety Executive), 2013. Occupational hygiene implications of processing waste at 
materials recycling facilities (MRFs). RR977 Research Report, 41 pp. 
L-Threonine produced by E. coli for all animal species 
 
 
 
www.efsa.europa.eu/efsajournal 10 EFSA Journal 2016;14(1):4344 
 
Kaper JB, Nataro JP and Mobley HLT, 2004. Pathogenic Escherichia coli. Nature Reviews Microbiology, 
2, 123–140. 
Luchi M and Morrison DC, 2000. Comparable endotoxic properties of lipopolysaccharides are manifest 
in diverse clinical isolates of Gram-negative bacteria. Infection and Immunity, 68, 1899–1904.  
Nataro JP and Kaper JB, 1998. Diarrheagenic Escherichia coli. Clinical Microbiology Reviews, 11, 142–
201. 
Rylander R, 1999. Health effects among workers in sewage treatment plants. Occupational 
Environmental Medicine, 56, 354–357. 
Svensson M, Han L, Silfersparre G, Haggstrom L and Enfors SO, 2005, Control of endotoxin release in 
Escherichia coli feed-batch cultures. Bioprocess and Biosystems Engineering, 27, 91–97. 
Thorn J, 2001. The inflammatory response in humans after inhalation of bacterial endotoxin: a review. 
Inflammatory Response, 50, 254–261. 
L-Threonine produced by E. coli for all animal species 
 
 
 
www.efsa.europa.eu/efsajournal 11 EFSA Journal 2016;14(1):4344 
 
Abbreviations 
 
CGMCC China General Microbiological Culture Collection Centre 
DECOS Dutch Expert Committee on Occupational Safety 
DNA deoxyribonucleic acid  
EC European Commission 
EPA Environmental Protection Agency of US 
FEEDAP EFSA Panel on Additives and Products or Substances used in Animal Feed 
GM genetically modified 
GMO EFSA Panel on Genetically Modified Organisms 
HBROEL Health-based recommended exposure limit  
HSE British Health and Safety Executive 
IU International unit of endotoxin activity. One IU corresponds to one EU (endotoxin unit). 
LPS 
PCR 
lipopolysaccharide 
polymerase chain reaction 
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Appendix – Safety for the user 
The effects of endotoxin inhalation and the exposure limits have been described in a previous opinion 
(EFSA FEEDAP Panel, 2015). 
Calculation of maximum acceptable levels of exposure from feed additives 
The likely exposure time according to EFSA guidance (EFSA FEEDAP Panel, 2012c) for additives added 
in premixtures assumes a maximum of 40 periods of exposure per day, each comprising 
20 s = 40  20 = 800 s per day. With an uncertainty factor of 2, maximum inhalation exposure would 
occur for 2  800 = 1 600 s = 0.444 h per day. Again, assuming a respiration volume of 1.25 m3/h, 
the inhalation volume providing exposure to potentially endotoxin-containing dust would be 
0.444  1.25 = 0.556 m3 per day. This volume should contain no more than 900 IU endotoxin, so the 
dust formed from the product should contain no more than 900/0.556 = 1 619 IU/m3. 
Calculation of endotoxin content of dust 
Two key measurements are required to evaluate the potential respiratory hazard associated with 
endotoxin content of the product (the dusting potential of the product, expressed in g/m3; the 
endotoxin activity of the dust, determined by the Limulus amoebocyte lysate assay (expressed in 
IU/g)). If data for the dust are not available, the content of endotoxins of the product can be used 
instead. If the content of endotoxins of the relevant additive is a IU/g and the dusting potential is 
b g/m3, then the content of endotoxins of the dust, c IU/m3, is obtained by the simple multiplication 
a  b. This resulting value is further used for calculation of potential inhalatory exposure by users to 
endotoxin from the additive under assessment (Table 2) (EFSA FEEDAP Panel, 2012c).  
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Table 2:  Estimation of user exposure to endotoxins from the additive L-threonine produced by 
Escherichia coli CGMCC 3703, including consideration of using filter mask FF P2 or FF P3 as 
preventative measure 
Calculation Identifier Description Amount Source 
 a Endotoxin content (IU/g product) 550 Technical dossier 
 b Dusting potential (g/m3) 0.13 Technical dossier 
a  b c Endotoxin content in the air (IU/m3)  71.5  
 d No of premixture batches made per working day 40 EFSA FEEDAP Panel 
(2012c) 
 e Time of exposure (s) per production of one batch 20 EFSA FEEDAP Panel 
(2012c) 
d  e f Total duration of daily exposure/worker (s) 800  
 g Uncertainty factor 2 EFSA FEEDAP Panel 
(2012c) 
f  g h Refined total duration of daily exposure/worker (s) 1 600  
h/3 600 i Refined total duration of daily exposure (h) 0.44  
 j Inhaled air (m3) per 8-hour working day 10 EFSA FEEDAP Panel 
(2012c) 
j/8  i k Inhaled air during exposure (m3) 0.56  
c  k l Endotoxin (IU) inhaled during exposure per 8-hour 
working day 
40  
 m Health-based recommended exposure limit of 
endotoxin (IU/m3) per 8-hour working day 
90 Health Council of the 
Netherlands (2010) 
m  j n Health-based recommended exposure limit of total 
endotoxin exposure (IU) per 8-hour working day 
900  
l/10  Endotoxins inhaled (IU) per 8-hour working day 
reduced by filter mask FF P2 (reduction factor 10) 
4.0  
l/20  Endotoxins inhaled (IU) per 8-hour working day 
reduced by filter mask FF P3 (reduction factor 20) 
2.0  
 
